ES556738A0 - Un procedimiento para la preparacion de nuevos piridazinaminas. - Google Patents
Un procedimiento para la preparacion de nuevos piridazinaminas.Info
- Publication number
- ES556738A0 ES556738A0 ES556738A ES556738A ES556738A0 ES 556738 A0 ES556738 A0 ES 556738A0 ES 556738 A ES556738 A ES 556738A ES 556738 A ES556738 A ES 556738A ES 556738 A0 ES556738 A0 ES 556738A0
- Authority
- ES
- Spain
- Prior art keywords
- piridazinamines
- procedure
- preparation
- new
- new piridazinamines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76084585A | 1985-07-31 | 1985-07-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8802151A1 ES8802151A1 (es) | 1988-04-01 |
| ES556738A0 true ES556738A0 (es) | 1988-04-01 |
Family
ID=25060338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES556738A Expired ES8802151A1 (es) | 1985-07-31 | 1986-06-25 | Un procedimiento para la preparacion de nuevos piridazinaminas. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0211457A3 (es) |
| JP (1) | JPS6229575A (es) |
| KR (1) | KR870001192A (es) |
| CN (1) | CN86105558A (es) |
| AU (1) | AU6073986A (es) |
| DK (1) | DK363186A (es) |
| ES (1) | ES8802151A1 (es) |
| FI (1) | FI863120A7 (es) |
| GR (1) | GR862022B (es) |
| HU (1) | HU195501B (es) |
| IL (1) | IL79549A0 (es) |
| NO (1) | NO863083L (es) |
| NZ (1) | NZ216918A (es) |
| PH (1) | PH22884A (es) |
| PT (1) | PT83098B (es) |
| TN (1) | TNSN86117A1 (es) |
| ZA (1) | ZA865700B (es) |
| ZW (1) | ZW14886A1 (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY104343A (en) * | 1987-11-23 | 1994-03-31 | Janssen Pharmaceutica Nv | Novel pyridizinamine deravatives |
| US4992433A (en) * | 1987-11-23 | 1991-02-12 | Janssen Pharmaceutica N.V. | Novel pyridazinamine derivatives |
| GB8911158D0 (en) * | 1989-05-16 | 1989-07-05 | Janssen Pharmaceutica Nv | Antiviral pyridazinamines |
| US5070090A (en) * | 1989-05-15 | 1991-12-03 | Janssen Pharmaceutica N.V. | Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers |
| US5270312A (en) * | 1990-11-05 | 1993-12-14 | Warner-Lambert Company | Substituted piperazines as central nervous system agents |
| BR9813279B1 (pt) * | 1997-10-27 | 2010-11-16 | derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina. | |
| JP2002543070A (ja) * | 1999-04-26 | 2002-12-17 | ニューロサーチ、アクティーゼルスカブ | ヘテロアリールジアザシクロアルカン類、その製造方法及びその使用方法 |
| EP1430033A4 (en) | 2001-08-31 | 2004-12-15 | Univ Northwestern | ANTI-INFLAMMATORY AND PROTEIN-INK-INHIBITING COMPOSITION AND THEIR USE |
| US7390813B1 (en) | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
| US7754711B2 (en) * | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| US7759348B2 (en) | 2003-07-30 | 2010-07-20 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| ES2386353T3 (es) * | 2003-07-30 | 2012-08-17 | Xenon Pharmaceuticals Inc. | Derivados de piridazina y su uso como agentes terapéuticos |
| TWI345974B (en) | 2003-07-30 | 2011-08-01 | Xenon Pharmaceuticals Inc | Pyridazine derivatives and their use in the inhibition of stearoyl-coa desaturase |
| MX2007003332A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa. |
| JP5149009B2 (ja) | 2004-09-20 | 2013-02-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体 |
| AU2005286728A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| MX2007003325A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa. |
| AR051090A1 (es) | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
| EP1830837B1 (en) | 2004-09-20 | 2013-09-04 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| AR051093A1 (es) | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de estearoil-coa desaturasa |
| WO2006050359A2 (en) | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
| AU2016203312B2 (en) * | 2004-11-02 | 2018-05-24 | Centre National De La Recherche Scientifique | Pyridazine compounds, compositions and methods |
| JP5337375B2 (ja) | 2004-11-02 | 2013-11-06 | ノースウェスタン ユニバーシティ | ピリダジン化合物、組成物および方法 |
| EP2029138A1 (en) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
| CA2650625A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| CA2650711A1 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
| MX2009011416A (es) | 2007-04-23 | 2009-11-05 | Janssen Pharmaceutica Nv | Tia(di)azoles como antagonistas del receptor de dopamina 2 de disociacion rapida. |
| KR20100016620A (ko) | 2007-04-23 | 2010-02-12 | 얀센 파마슈티카 엔.브이. | 속해리성 도파민 2 수용체 길항제로서의 4-알콕시피리다진 유도체 |
| WO2008145681A2 (en) * | 2007-05-31 | 2008-12-04 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists and uses thereof |
| KR101609218B1 (ko) | 2008-07-31 | 2016-04-05 | 얀센 파마슈티카 엔.브이. | 속해리성 도파민 2 수용체 길항제로서의 피페라진-1-일-트리플루오로메틸-치환된-피리딘 |
| US9260400B2 (en) | 2011-05-24 | 2016-02-16 | Universita' Degli Studi Di Bari “Aldo Moro” | I-arylpiperazinic ligands of 5-HT7 receptor and use thereof |
| BR112017028492B1 (pt) | 2015-07-02 | 2023-12-26 | Centrexion Therapeutics Corporation | Citrato de (4-((3r,4r)-3-metoxitetra-hidro-piran-4- ilamino)piperidin-1-il) (5- metil-6-(((2r, 6s)-6-(p-tolil) tetra-hidro-2h-piran-2-il)metilamino)pirimidin-4-il) metanona, seu uso e seu método de preparação, e composição farmacêutica |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985657A (en) * | 1959-10-12 | 1961-05-23 | Paul A J Janssen | 1-(aroylalkyl)-4-heterocyclylpiperazines |
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
-
1986
- 1986-06-25 ES ES556738A patent/ES8802151A1/es not_active Expired
- 1986-07-09 EP EP86201203A patent/EP0211457A3/en not_active Withdrawn
- 1986-07-14 KR KR1019860005671A patent/KR870001192A/ko not_active Withdrawn
- 1986-07-21 NZ NZ216918A patent/NZ216918A/xx unknown
- 1986-07-23 JP JP61171940A patent/JPS6229575A/ja active Pending
- 1986-07-28 PH PH34070A patent/PH22884A/en unknown
- 1986-07-28 CN CN198686105558A patent/CN86105558A/zh active Pending
- 1986-07-29 TN TNTNSN86117A patent/TNSN86117A1/fr unknown
- 1986-07-29 IL IL79549A patent/IL79549A0/xx unknown
- 1986-07-30 FI FI863120A patent/FI863120A7/fi not_active IP Right Cessation
- 1986-07-30 ZW ZW148/86A patent/ZW14886A1/xx unknown
- 1986-07-30 ZA ZA865700A patent/ZA865700B/xx unknown
- 1986-07-30 GR GR862022A patent/GR862022B/el unknown
- 1986-07-30 NO NO863083A patent/NO863083L/no unknown
- 1986-07-30 PT PT83098A patent/PT83098B/pt unknown
- 1986-07-30 DK DK363186A patent/DK363186A/da not_active Application Discontinuation
- 1986-07-30 HU HU863248A patent/HU195501B/hu unknown
- 1986-07-31 AU AU60739/86A patent/AU6073986A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FI863120A7 (fi) | 1987-02-01 |
| AU6073986A (en) | 1987-02-05 |
| DK363186A (da) | 1987-02-01 |
| GR862022B (en) | 1986-12-24 |
| NZ216918A (en) | 1988-11-29 |
| JPS6229575A (ja) | 1987-02-07 |
| ES8802151A1 (es) | 1988-04-01 |
| HU195501B (en) | 1988-05-30 |
| ZA865700B (en) | 1988-03-30 |
| EP0211457A2 (en) | 1987-02-25 |
| DK363186D0 (da) | 1986-07-30 |
| IL79549A0 (en) | 1986-10-31 |
| PT83098A (en) | 1986-08-01 |
| KR870001192A (ko) | 1987-03-12 |
| PH22884A (en) | 1989-01-19 |
| HUT41772A (en) | 1987-05-28 |
| NO863083L (no) | 1987-02-02 |
| CN86105558A (zh) | 1987-01-28 |
| TNSN86117A1 (fr) | 1990-01-01 |
| PT83098B (en) | 1988-07-13 |
| FI863120A0 (fi) | 1986-07-30 |
| ZW14886A1 (en) | 1988-02-24 |
| EP0211457A3 (en) | 1987-07-22 |
| NO863083D0 (no) | 1986-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES555834A0 (es) | Un procedimiento para la preparacion de nuevas piranopiridinas. | |
| ES551249A0 (es) | Un procedimiento para la preparacion de peptidilaminodioles. | |
| ES556738A0 (es) | Un procedimiento para la preparacion de nuevos piridazinaminas. | |
| ES553044A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina. | |
| ES554405A0 (es) | Un procedimiento para la preparacion de derivados de aza-indol. | |
| ES556550A0 (es) | Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas. | |
| ES545464A0 (es) | Un procedimiento para la preparacion de tetrahidroftalimidas. | |
| ES540705A0 (es) | Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas. | |
| ES556127A0 (es) | Un procedimiento para la preparacion de quinolinas 2-sustituidas. | |
| ES554983A0 (es) | Un procedimiento para la preparacion de silileteres. | |
| ES552189A0 (es) | Un procedimiento para la preparacion de derivados de piridimilmidazolidiona. | |
| ES540609A0 (es) | Un procedimiento para la preparacion de pirazolo piridinas. | |
| ES540610A0 (es) | Un procedimiento para la preparacion de pirazolopiridinas. | |
| ES546872A0 (es) | Un procedimiento para la preparacion de aminoalcoxibenzopiranonas. | |
| ES544521A0 (es) | Un procedimiento para la preparacion de triazolobenzodiazefinas. | |
| ES552297A0 (es) | Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos. | |
| ES541781A0 (es) | Un procedimiento para la preparacion de nuevos benzotiopenos. | |
| ES553874A0 (es) | Un procedimiento para la preparacion de metanosulfonatos de dioxolano. | |
| ES555369A0 (es) | Un procedimiento para la preparacion de un polialquenoilisocianato. | |
| ES547805A0 (es) | Un procedimiento para la preparacion de nuevos derivados de guanina. | |
| ES557772A0 (es) | Un procedimiento para la preparacion de epipodofilotoxina | |
| ES547205A0 (es) | Un procedimiento para la preparacion de nuevas quinazolindionas. | |
| ES555723A0 (es) | Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas. | |
| ES555298A0 (es) | Un procedimiento para la preparacion de nuevos esteroides 11-b-sustituidos. | |
| ES553703A0 (es) | Un procedimiento para la preparacion de vesiculas de fosfoliptidos. |